Biofrontera's Phase 3 Ameluz trial for AK on extremities/neck posts results after completionAug 21Trial updateaminolevulinic acidBiofrontera Inc.
Biofrontera reports Q2 2026 results, cites pending sBCC decision and pipeline dataAug 13Quarterly updateaminolevulinic acidBiofrontera Inc.
Sign inSign in